No difference in clinical outcomes using follitropin alfa (biosimilar) compared to follitropin alfa or follitropin beta for controlled ovarian stimulation (COS) in oocyte donation-recipient cycles

Subjects

Subjects :

0301 basic medicine
030219 obstetrics & reproductive medicine
business.industry
Follitropin beta
Obstetrics and Gynecology
Biosimilar
Stimulation
Follitropin alfa
Andrology
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Reproductive Medicine
Oocyte donation
Medicine
business

Details

ISSN :

00150282

Volume :

110

Database :

OpenAIRE

Journal :

Fertility and Sterility

Accession number :

edsair.doi...........623eb6946e2f3545ab22e2c9f3a1ddac

Full Text :

https://doi.org/10.1016/j.fertnstert.2018.07.941